← Back to headlines
AtaiBeckley Inc. Anticipates Phase 2 Results for Psychedelic Medicine
AtaiBeckley Inc. (ATAI) is poised as a psychedelic medicine opportunity ahead of its upcoming Phase 2 results, which are highly anticipated by investors.
15 Jul, 09:22 — 15 Jul, 09:22
Sources
Showing 1 of 1 sources
Related Stories
Hochschild Mining Reports 62% Revenue Surge in First Half
24m ago
TWG Global Denies Fraud Allegations Amid Federal Investigation
28m ago
Jennifer Garner Reveals Post-Divorce Financial Fears Sparked Career Shift
30m ago
Increased Nickel Exposure Detected in Several CATL Debrecen Employees, Work Suspended in Three Plants
36m ago